En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
10129.1;6 PFDP-LS
Titre du projet
Development of assay systems to screen T cell subsets in patients undergoing immunosuppressive therapy including coronin 1 mediated interventions and to screen for and design potential inhibitors of coronin 1.
Titre du projet anglais
Development of assay systems to screen T cell subsets in patients undergoing immunosuppressive therapy including coronin 1 mediated interventions and to screen for and design potential inhibitors of coronin 1.

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
Anzeigen
-
-
Anzeigen
Résumé des résultats (Abstract)
Anzeigen
-
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Allemand)
Development of assay systems to screen T cell subsets in patients undergoing immunosuppressive therapy including coronin 1 mediated interventions and to screen for and design potential inhibitors of coronin 1.
Description succincte
(Anglais)
Development of assay systems to screen T cell subsets in patients undergoing immunosuppressive therapy including coronin 1 mediated interventions and to screen for and design potential inhibitors of coronin 1.
Résumé des résultats (Abstract)
(Allemand)
The leukocyte specific molecule coronin 1 is required for the survival of naïve T cells. Inhibition of coronin 1 is a novel approach in immunosuppressive therapy. The first goal is to develop a T cell subsets screening procedure to follow patients undergoing immunosuppressive therapy, to analyze the correlation between paucity of naïve T cells and effectiveness of immunosuppression. The second goal of the project is to develop a diagnostic assay to be used for screening potential coronin 1 inhibitors.
Résumé des résultats (Abstract)
(Anglais)
The leukocyte specific molecule coronin 1 is required for the survival of naïve T cells. Inhibition of coronin 1 is a novel approach in immunosuppressive therapy. The first goal is to develop a T cell subsets screening procedure to follow patients undergoing immunosuppressive therapy, to analyze the correlation between paucity of naïve T cells and effectiveness of immunosuppression. The second goal of the project is to develop a diagnostic assay to be used for screening potential coronin 1 inhibitors.